TB and COVID-19 coinfection can lead to a dysregulated immune response; patients with active TB and COVID-19 commonly exhibit decreased total lymphocyte counts and impaired CD4 T-cell responses, potentially exacerbating disease severity. Here, CD4 is linked to tuberculosis.